Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-24-000243
Filing Date
2024-04-03
Accepted
2024-04-03 20:41:46
Documents
2
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 42306
2 EX-24 DOCUMENT attachment1.htm EX-24 5155
  Complete submission text file 0000899243-24-000243.txt   49064
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 24821245